There are 3161 resources available
LBA21 - Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)
Presenter: Giuseppe Viale
Session: Mini oral session 1: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1970MO - Circulating tumor DNA (ctDNA) clearance with neoadjuvant durvalumab (D) + tremelimumab (T) + enfortumab vedotin (EV) for cisplatin-ineligible muscle-invasive bladder cancer (MIBC) from the safety run-in cohort of the phase III VOLGA trial
Presenter: Alexandra Drakaki
Session: Mini oral session: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Toxicity of ADCs
Presenter: Anne-Marie Dingemans
Session: Antibody drug conjugates (ADCs) in lung cancer: Ready for prime time?
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session 1: GI tumours, lower
Resources:
Webcast
Q&A and discussion
Session: Non-cutaneous melanoma and non-melanoma skin cancers: There is much more we can do
Resources:
Webcast
Moving on from PD-1-CTLA-4 blockade
Presenter: Sophia Yien Ning Wong
Session: Next generation of combinations in early clinical trials
Resources:
Slides
Webcast
Rectal cancer
Presenter: Eric Van Cutsem
Session: POWG 2: Optimal perioperative systemic treatment in different tumours
Resources:
Slides
Webcast
Invited Discussant LBA85, 1964MO and 1970MO
Presenter: Maria De Santis
Session: Mini oral session: GU tumours, non-prostate
Resources:
Slides
Webcast
Invited Discussant 710MO, LBA33 and LBA34
Presenter: Alexandra Leary
Session: Mini oral session 1: Gynaecological cancers
Resources:
Slides
Webcast
Invited Discussant 445MO, 446MO and 447MO
Presenter: Giuseppe Lombardi
Session: Mini oral session: CNS tumours
Resources:
Slides
Webcast